Printer Friendly

PSS World Medical, Inc. Reports First Quarter Results.

JACKSONVILLE, Fla.--(BUSINESS WIRE)--July 21, 1998--

First Quarter Highlights:

-- Pro forma net income per share increased 31% -- Accelerated integration of Gulf South on schedule -- Gulf South accounting periods and methods conformed to those of

PSS -- New exclusive agreement for PSS

PSS World Medical, Inc. (Nasdaq/NM:PSSI) today announced results for the first quarter ended June 30, 1998.

For the three months ended June 30, 1998, net sales increased 19% to $342.5 million compared with $288.2 million for the same period last year. Pro forma net income, excluding merger and other nonrecurring costs and expenses, for the quarter increased 33% to $11.7 million, or $0.17 per diluted share, on 70.7 million weighted average shares outstanding versus $8.8 million, or $0.13 per diluted share, on 68.1 million weighted average shares outstanding for the prior year period. Net income for the three months ended June 30, 1998, was $11.3 million, or $0.16 per diluted share.

Patrick C. Kelly, chairman and chief executive officer of PSS World Medical, Inc., said, "We are pleased with our results for the first quarter of 1998, which are on target or ahead of analysts expectations. Our integration of Gulf South is moving rapidly and on schedule. We are very pleased with the progress of our management team and their actions to position Gulf South as the market leader. In addition, the accounting periods and methods of Gulf South have been conformed to those of PSS World Medical."

Mr. Kelly also stated that both the Physician and Imaging operations are performing well despite distractions from the merger with Gulf South. The Physician division just entered into another new exclusive agreement with Critikon, a Johnson & Johnson company, the United States market leader of multiparameter heart monitors. This new exclusive is for Critikons DINAMAP(R) heart monitors and DURA-CUF(R) blood pressure cuffs. Also, Diagnostic Imaging continues to gain momentum and perform ahead of our expectations with its continued focus on unique customer services and sophisticated product sales.

During our first quarter of operations following the merger, Gulf South purchased the assets of Chattanooga, Tennessee-based National Medical, LLC, a privately held distributor to the home health care marketplace, with annualized revenues of approximately $7 million.

In addition, the Company's other subsidiaries completed a number of strategic acquisitions during the first quarter. Diagnostic Imaging also expanded through the purchase of the assets of Danville, Pennsylvania-based North Central X-Ray, Inc., serving Central Pennsylvania, and the stock-for-stock acquisition of Little Rock, Arkansas-based Medical Imaging Services, Inc., with combined annualized revenues of approximately $30 million. Physician Sales & Service purchased the assets of three physician medical supply companies, with total combined annualized revenues of approximately $5 million.

PSS World Medical is the largest distributor of medical supplies, equipment and pharmaceuticals to office-based physicians in the United States through its Physician Sales & Service Division. Through its Gulf South Medical Supply subsidiary, the Company is a leading national distributor of medical supplies and related products to the long-term care industry. In addition, the Company is the leading distributor of medical diagnostic imaging supplies, chemicals, equipment, and service to the acute care and alternate-care markets through its subsidiary, Diagnostic Imaging, Inc.

This news release contains forward-looking statements and information that are subject to certain risks, trends and uncertainties detailed in the company's reports filed with the Securities and Exchange Commission, including business and economic conditions, as well as conditions affecting the health care industry, competitive forces and the ability to integrate acquired operations successfully, that could cause results to differ materially from those projected. -0-
 Unaudited Consolidated Operating Highlights
 Including Pro Forma Net Income and Net Income Per Share
 (In millions, except per share data)

 Three Months Ended June 30,
 Percent of Percent of Percent
 1998 Net Sales 1997 Net Sales Change
Net sales $ 342.5 100.0% $ 288.2 100.0% 19%
Gross profit 94.9 27.7% 76.8 26.6% 24%
Selling, general
 and administrative
 expenses 75.0 21.9% 63.0 21.9% 19%
Merger and other
 nonrecurring costs
 and expenses .3 .1% 1.4 .5% (79)%
Operating income 19.6 5.7% 12.4 4.3% 58%
Net income $ 11.3 3.3% $ 7.9 2.7% 43%
Basic earnings per
 share $ 0.16 $ 0.12
Diluted earnings
 per share $ 0.16 $ 0.12
Pro forma operating
 income $ 19.9 5.8% $ 13.8 4.8% 44%
Pro forma net income
 excluding merger
 and other
 nonrecurring costs
 and expenses $ 11.7 3.4% $ 8.8 3.1% 33%
Pro forma diluted
 earnings per share
 excluding merger
 and nonrecurring
 costs and expenses $ 0.17 $ 0.13 31%

Weighted average shares:
 Basic 69,858 67,285
 Diluted 70,727 68,059

CONTACT: PSS World Medical Inc., Jacksonville

David A. Smith, 904/332-3000


Thomas A. Crowley, Jr., 973/783-1510
COPYRIGHT 1998 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1998, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 21, 1998
Previous Article:McMoRan Oil & Gas Co. Reports Second-quarter and Six-month 1998 Results.
Next Article:REPEAT/Wildfire Capital Corporation and Pacific Magtron Inc. Complete Transaction.

Related Articles
Physician Sales & Service Inc. reports record first quarter sales and earnings.
PSS World Medical, Inc. Accelerates Gulf South Medical Supply Integration Efforts and Conforms Accounting Practices.
PSS World Medical, Inc. Reports Record Second Quarter Results.
PSS World Medical, Inc. Reports Record First Quarter Results.
PSS World Medical First Quarter Results Show Strong Improvement Over Fourth Quarter; Exceeds EBITDA Condition of Fisher Scientific Acquisition.
PSS World Medical Announces Credit Rating Upgrade.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters